![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 15, 7020-7028, May, 1988
K Kaur, T Coons, K Emmett and B Ullman
From a mutagenized population of wild type Leishmania donovani
promastigotes, a clone was isolated in a single step by virtue of its
resistance to 1 mM methotrexate, a potent inhibitor of dihydrofolate
reductase. This methotrexate-selected cell line, MTXA5, was cross-
resistant to aminopterin but just as sensitive to growth inhibition caused
by pyrimethamine, trimethoprim, and cytotoxic purine and pyrimidine
analogs. Unlike previously characterized methotrexate- resistant Leishmania
(Coderre, J. A., Beverley, S. M., Schimke, R., and Santi, D. V. (1983)
Proc. Natl. Acad. Sci. U. S. A. 80, 2132-2136), resistance to the
antimetabolite was not due to gene amplification or increased dihydrofolate
reductase activity. The genetic defect in MTXA5 cells appeared to be in the
methotrexate-folate transport system. The rate of uptake and transport of
[3H]methotrexate and [3H]folate into MTXA5 cells was less than 1% of that
of wild type parental cells. Neither wild type nor MTXA5 cells could
multiply in folate-deficient medium, and thymine and thymidine at
concentrations which circumvented methotrexate toxicity, did not restore
the ability of Leishmania to grow. The concentration of exogenous folate
that restored growth of wild type and mutant cells, however, was virtually
identical, although MTXA5 cells, unlike parental cells, could not
proliferate in folate- deficient medium supplemented with 10 microM
biopterin. Interestingly, methotrexate and aminopterin could stimulate the
growth of both leishmanial strains in folate-deficient medium, suggesting
that these antifolate analogs were serving as a pteridine source for the
parasite. These somatic cell genetic studies of folate transport in
Leishmania provide genetic evidence for a specific folate permease in L.
donovani promastigotes and have important implications concerning the
mechanisms by which these parasites utilize exogenous pteridines and
folates and by which they might become resistant to parasite-directed
chemotherapeutic regimens.
Methotrexate-resistant Leishmania donovani genetically deficient in the folate-methotrexate transporter
Department of Biochemistry, Oregon Health Sciences University, Portland 07021.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Richard, P. Leprohon, J. Drummelsmith, and M. Ouellette Growth Phase Regulation of the Main Folate Transporter of Leishmania infantum and Its Role in Methotrexate Resistance J. Biol. Chem., December 24, 2004; 279(52): 54494 - 54501. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. El Fadili, C. Kundig, G. Roy, and M. Ouellette Inactivation of the Leishmania tarentolae Pterin Transporter (BT1) and Reductase (PTR1) Genes Leads to Viable Parasites with Changes in Folate Metabolism and Hypersensitivity to the Antifolate Methotrexate J. Biol. Chem., April 30, 2004; 279(18): 18575 - 18582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Richard, C. Kundig, and M. Ouellette A New Type of High Affinity Folic Acid Transporter in the Protozoan Parasite Leishmania and Deletion of Its Gene in Methotrexate-resistant Cells J. Biol. Chem., August 9, 2002; 277(33): 29460 - 29467. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nare, L. W. Hardy, and S. M. Beverley The Roles of Pteridine Reductase 1 and Dihydrofolate Reductase-Thymidylate Synthase in Pteridine Metabolism in the Protozoan Parasite Leishmania major J. Biol. Chem., May 23, 1997; 272(21): 13883 - 13891. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |